Gregory Scott Duncan - Jun 23, 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Stock symbol
VIRI
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/30/2022, 01:38 PM
Previous filing
May 24, 2022
Next filing
Feb 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +90K $0.00 90K Jun 23, 2022 Common Stock 90K $4.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter.